Human papillomavirus DNA detection in menstrual blood from patients with cervical intraepithelial neoplasia and condyloma acuminatum

Journal of Clinical Microbiology

Volumn 48, Issue 3, 2010, Pages 709-713

  Wong, Sze Chuen Cesar ^a   Au, Thomas Chi Chuen ^a   Chan, Sammy Chung Sum ^b   Chan, Charles Ming Lok ^a   Lam, Money Yan Yee ^a   Zee, Benny Chung Ying ^a   Pong, Wei Mei ^b   Chan, Anthony Tak Cheung ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CANCER REGRESSION; CANCER THERAPY; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MENSTRUATION; NONHUMAN; PRECANCER; PREDICTION AND FORECASTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SCREENING; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; UTERINE CERVIX CARCINOMA IN SITU; VIRAL GENETICS; VIRUS LOAD; WART VIRUS;

ADOLESCENT; ADULT; BLOOD; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONDYLOMATA ACUMINATA; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MENSTRUATION; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 77749286761     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01996-09     Document Type: Article

References (19)

1. Bello, B. D., A. Spinillo, P. Alberizzi, S. Cesari, B. Gardella, G. D'Ambrosio, M. Roccio, and E. M. Sillini. 2009. Cervical infections by multiple human papillomavirus (HPV) genotypes: prevalence and impact on the risk of precancerous epithelial lesions. J. Med. Virol. 81:703-712.
2. Chan, P. K., W. C. Ho, M. C. Wong, A. R. Chang, J. S. Chor, and M. Y. Yu. 2009. Epidemiologic risk profile of infection with different groups of human papillomaviruses. J. Med. Virol. 81:1635-1644.
3. Goldie, S. J., L. Gaffikin, J. D. Goldhaber-Fiebert, A. B. Gordillo-Tobar, C. Levin, C. Mahé, T. C. Wright, and Alliance for Cervical Cancer Prevention Cost Working Group. 2005. Cost-effectiveness of cervical-cancer screening in five developing countries. N. Engl. J. Med. 353:2158-2168.
4. Harper, D. M., M. Raymond, W. W. Noll, D. R. Belloni, L. T. Duncan, and B. F. Cole. 2002. Tampon samplings with longer cervicovaginal cell exposures are equivalent to two consecutive swabs for the detection of high-risk human papillomavirus. Sex. Transm. Dis. 29:628-636.
5. Josefsson, A. M., P. K. Magnusson, N. Ylitalo, P. Sørensen, P. Qwarforth-Tubbin, P. K. Andersen, M. Melbye, H. O. Adami, and U. B. Gyllensten. 2000. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355:2189-2193.
6. Kovács, K., A. D. Varnai, M. Bollmann, A. Bankfalvi, M. Szendy, N. Speich, C. Schmitt, L. Pajor, and R. Bollmann. 2008. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany. J. Med. Virol. 80:1814-1823.
7. Moreira, E. D., Jr., B. G. Oliveira, F. M. Ferraz, S. Costa, J. O. Costa Filho, and G. Karic. 2006. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention. Int. J. Gynecol. Cancer 16:599-603.
8. Ogilvie, G. S., D. M. Patrick, M. Schulzer, J. W. Sellors, M. Petric, K. Chambers, R. White, and J. M. FitzGerald. 2005. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex. Transm. Infect. 81:207-212.
9. Qu, W., G. Jiang, Y. Cruz, C. J. Chang, G. Y. Ho, R. S. Klein, and R. D. Burk. 1997. PCR detection of human papillomavirus: comparison between MY09/ MY11 and GP5+/GP6+ primer systems. J. Clin. Microbiol. 35:1304-1310.
10. Roden, R., and T. C. Wu. 2006. How will HPV vaccines affect cervical cancer? Nat. Rev. Cancer 6:753-763.
11. Runowicz, C. D. 2007. Molecular screening for cervical cancer - time to give up Pap tests? N. Engl. J. Med. 357:1650-1653.
12. Sankaranarayanan, R., B. M. Nene, S. S. Shastri, K. Jayant, R. Muwonge, A. M. Budukh, S. Hingmire, S. G. Malvi, R. Thorat, A. Kothari, R. Chinoy, R. Kelkar, S. Kane, S. Desai, V. R. Keskar, R. Rajeshwarkar, N. Panse, and K. A. Dinshaw. 2009. HPV screening for cervical cancer in rural India. N. Engl. J. Med. 360:1385-1394.
13. Sanner, K., I. Wikström, A. Strand, M. Lindell, and E. Wilander. 2009. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br. J. Cancer 101:871-874.
14. Sideri, M., P. Cristoforoni, C. Casadio, S. Boveri, S. Igidbashian, M. Schmitt, T. Gheit, and M. Tommasino. 2009. Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series. Vaccine 27(Suppl. 1):A30-A33.
15. Sotlar, K., D. Diemer, A. Dethleffs, Y. Hack, A. Stubner, N. Vollmer, S. Menton, M. Menton, K. Dietz, D. Wallwiener, R. Kandolf, and B. Bültmann. 2004. Detection and typing of human papillomavirus by e6 nested multiplex PCR. J. Clin. Microbiol. 42:3176-3184.
16. Tong, T. R., O. W. Chan, T. C. Chow, V. Yu, K. M. Leung, and S. H. To. 2003. Detection of human papillomavirus in sanitary napkins: a new paradigm in cervical cancer screening. Diagn. Cytopathol. 28:140-141.
17. Woodman, C. B., S. I. Collins, and L. S. Young. 2007. The natural history of cervical HPV infection: unresolved issues. Nat. Rev. Cancer 7:11-22.
18. Wright, T. C., Jr., L. Denny, L. Kuhn, A. Pollack, and A. Lorincz. 2000. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 283:81-86.
19. Ylitalo, N., P. Sørensen, A. M. Josefsson, P. K. Magnusson, P. K. Andersen, J. Pontén, H. O. Adami, U. B. Gyllensten, and M. Melbye. 2000. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355:2194-2198.